UT MD Anderson shared on X:
“Now published in Journal of Clinical Oncology, Phase 3 ROADS trial findings show tile-based radiation therapy delivered during surgery significantly improved tumor control and more than doubled median overall survival in patients with brain metastases.
Read more: Researchers suggest tile-based radiation therapy as standard of care to lower risk of recurrence in brain metastases.”
Other articles about radiation therapy on OncoDaily.